Pharma & Life Sciences

The pharma and life sciences sector is home to some of the world’s largest companies, pursuing cutting-edge innovations, negotiating huge transactions and fighting complex disputes. Our large life sciences legal team has a wealth of experience. We advise and help clients win litigation and survive regulatory attacks in this very challenging field.

The life sciences sector itself has been consolidating, and some pharmaceuticals originators are moving into production of generics. Small and midsize companies develop new pharmaceuticals that they commercialize through licensing deals and technology transactions. These companies are subject to mergers and acquisitions, and national and European regulatory frameworks are constantly developing and changing.

Our lawyers have the experience and expertise to handle long-running patent disputes, multinational transactions and complex regulatory changes. We have the kind of experience that allows us to anticipate potential problems before they arise and to design innovative strategies to solve them. The team members also have substantial in-house experience in the pharmaceutical industry, which ensures that we never lose sight of the client perspective.

Related news

  • Recent work| October 28, 2024

    Frazier Life Sciences’ additional investment in Egetis Therapeutics

  • Recent work| October 23, 2024

    Roschier represented Sanofi in connection with its investment in Vicore

  • Recent work| April 10, 2024

    Roschier represented EQT and Recipharm in the carve-out of seven of Recipharm’s CDMO sites in Sweden, Spain and France

  • Recent work| March 20, 2024

    Roschier represented RV Invest and Johnson & Johnson Innovation – JJDC, Inc in a EUR 30 million financing round of Asgard Therapeutics

  • Recent work| October 12, 2023

    Roschier represented Frazier Life Sciences in its investment in Egetis Therapeutics

  • Recent work| March 30, 2023

    Roschier acts as legal advisor to Navamedic in the recommended cash offer to acquire Sensidose

  • Recent work| February 23, 2023

    Roschier represented KKR’s life science platform Gamma in the sale of Astrea to Biotage

  • Insights| August 22, 2022

    Amendments to pharmaceutical legislation to create savings on public medical costs

  • Recent work| August 17, 2022

    Roschier represents Karo Pharma in connection with EQT’s public cash offer to the shareholders in the company

  • Insights| July 21, 2022

    ICLG Pharmaceutical Advertising Laws and Regulations 2022 published

  • Recent work| July 6, 2022

    Roschier represented Bonnier Ventures in their investment in diagnostics company Elypta

  • Recent work| April 4, 2022

    Roschier represented Axcel in its divestment of Aidian to Nordstjernan

  • Recent work| January 26, 2022

    Roschier represented Nordstjernan in its investment in medtech company Ascilion

  • Recent work| December 3, 2021

    Roschier represented Sedana Medical in connection with its SEK 615 million private placement of new shares

  • Recent work| November 25, 2021

    Referral to the CJEU from the Finnish Market Court on the interpretation of Article 3(c) of the SPC Regulation

  • Recent work| November 23, 2021

    Roschier acted for the owners of Sylphar International in the sale of the company to Karo Pharma

  • Recent work| September 2, 2021

    Roschier acts for Agnafit Bidco in the SEK 69.4 billion public offer to the shareholders of Sobi

  • Events| August 12, 2021

    Joint webinar: Health applications and pharma advertising

  • Insights| July 19, 2021

    ICLG Pharmaceutical Advertising Laws and Regulations 2021 published

  • Recent work| March 25, 2021

    Roschier represents Orkla in the acquisition of VitaePro and Oslo Skin Lab

  • Recent work| December 14, 2020

    Roschier advised EQT IX and Roar BidCo in their SEK 23.6 billion public offer for Recipharm

  • Insights| August 28, 2020

    Legislative proposal would allow the Swedish state to prohibit foreign takeovers of importance to national security

  • Insights| August 4, 2020

    ICLG Pharmaceutical Advertising Laws and Regulations 2020 published

  • Recent work| May 20, 2020

    Roschier advised Elekta in its acquisition of Kaiku Health

  • Insights| February 13, 2020

    The CJEU rules on access to documents submitted when applying for marketing authorization

  • Recent work| January 31, 2020

    Roschier represented Quest Diagnostics in its acquisition of Blueprint Genetics

  • Recent work| January 21, 2020

    Roschier represented Patricia Industries in Apoteket’s investment in Doktor24

  • Insights| December 16, 2019

    Third-party funding – a way to turn your legal department into a profit center

  • Insights| November 19, 2019

    Secondary use of health data – the new Finnish Act

  • Insights| October 31, 2019

    News from our Data Protection practice

  • Insights| October 25, 2019

    The EU’s Medical Device and In Vitro Medical Device Regulations – What Will Change?

  • Insights| October 3, 2019

    Finnish Market Court found PEGORATIO to be confusingly similar to PEGORION

  • Insights| June 26, 2019

    C-55/18 CCOO – A Case for Clocking In?

  • Insights| June 25, 2019

    ICLG Pharmaceutical Advertising 2019 (Finland chapter)

  • Insights| June 11, 2019

    Amendments to the Finnish Competition Act to enter into force in June 2019

  • Insights| May 10, 2019

    Climate change and employment in Finland?

  • Insights| April 26, 2019

    The new Finnish Trademarks Act ratified by the President of Finland

  • Events| April 17, 2019

    Upcoming Roschier Reflections: Performance management – breaking the myths, Tuesday 14 May 2019

  • Insights| April 4, 2019

    Prerequisites for Measures for Preserving Evidence in IPR Cases Clarified

  • Insights| April 1, 2019

    New concept of “extra days off” in Finnish Annual Holidays Act

  • Events| March 28, 2019

    Upcoming Roschier Reflections: Capital Markets Breakfast, Thursday 25 April 2019

  • Insights| March 22, 2019

    New Working Hours Act passed

  • Events| March 5, 2019

    Upcoming Roschier Reflections: Corporate Taxation, 19 March 2019

  • Recent work| February 13, 2019

    Roschier advises in Moberg Pharma OTC acquisition

  • Recent work| February 12, 2019

    Roschier represented NextPharma in the acquisition of a manufacturing facility and related operations in Tampere

  • Recent work| January 18, 2019

    Roschier acted for 3i on its sale of OneMed to Nalka

  • Events| January 11, 2019

    Invitation: Roschier IP Horizons 2019

  • Insights| December 20, 2018

    After a long silent period, the FCCA has issued a fining proposal against ThermiSol Oy and UK-Muovi Oy alleging a cartel in EPS insulation

  • Insights| December 14, 2018

    The world’s most complicated restrictions on the deductibility of interest expenses for tax purposes – what to expect next year?

  • Insights| December 5, 2018

    Remaining uncertainty regarding legal requirements in labour migration

  • Insights| December 4, 2018

    The Swedish Supreme Court has its say regarding dawn raids and the right to appeal the Swedish Competition Authority’s conduct during a raid

  • Insights| December 3, 2018

    Mandatory safety features of medicinal products for human use become applicable in February 2019

  • Insights| November 15, 2018

    Parliament of Finland approves new Data Protection Act

  • Insights| November 15, 2018

    Government proposes changes to the taxation of cross border investments

  • Events| November 12, 2018

    Upcoming Roschier Reflections: Trademark Breakfast on Tuesday 27 November 2018

  • Events| November 7, 2018

    Meet the Finnish IP Judges on 26 November 2018

  • Insights| October 18, 2018

    New Finnish Trademarks Act

  • Insights| October 17, 2018

    Oral hearings in tax disputes

  • Insights| October 12, 2018

    Commission Proposal to Change the Regulation on Supplementary Protection Certificates

  • Firm news| October 12, 2018

    Roschier strengthens its IP and life sciences offering in Sweden

  • Events| October 11, 2018

    Upcoming Roschier Reflections: Breakfast Seminar on Trade Secrets, 24.10.2018

  • Events| September 10, 2018

    Expert talk with Swedish Trademark Judges

  • Events| August 27, 2018

    Upcoming event: Breakfast seminar with Andrew McAfee and Chrissie Lightfoot

  • Insights| August 23, 2018

    A New Trade Secrets Act Now in Force in Finland

  • Insights| July 24, 2018

    Commission fines Asus, Denon & Marantz, Philips and Pioneer for artificially maintaining high prices of their online distributors

  • Insights| June 27, 2018

    Update on the Finnish Trademark law Reform and Finnish Bar Association’s statement on the draft proposal for a Government Bill to the Parliament

  • Insights| June 26, 2018

    ICLG Pharmaceutical Advertising 2018 (Finland chapter)

  • Insights| June 20, 2018

    Mergers & Acquisitions – Due Diligence in M&A

  • Insights| June 12, 2018

    Mergers & Acquisitions – Choosing the Structure: Mergers, Joint Ventures, Licensing Agreements and Public Tender Offers

  • Insights| June 4, 2018

    Mergers & Acquisitions – Choosing the Structure: Private Share Purchases and Business Acquisitions

  • Events| May 24, 2018

    Recent developments in Competition Law – Roschier Reflections seminar on 22 May 2018

  • Insights| May 16, 2018

    New legislation regarding variable working time

  • Recent work| May 16, 2018

    Roschier represented Axcel Management in the acquisition of Orion Diagnostica

  • Insights| April 25, 2018

    Commission fines Altice EUR 125 million for gun-jumping

  • Insights| April 24, 2018

    A Swedish Perspective on Third Party Funding

  • Insights| April 23, 2018

    Finnish Government Proposal on the Data Protection Act and Supplementary Laws in Finland

  • Insights| April 19, 2018

    Recent decisions of The Finnish Competition and Consumer Authority and Finnish Market Court relating to public procurement contracts

  • Events| April 18, 2018

    IPR University Center’s event held at Roschier´s Helsinki office

  • Events| April 16, 2018

    Työoikeudellinen Yhdistys ry arranged their fully booked anniversary seminar at Roschier´s premises

  • Events| April 9, 2018

    Roschier and the International Trademark Association (INTA) are hosting INTA Roundtable: 3D Trademarks – What´s New?

  • Events| March 28, 2018

    Launch of the Roschier Disputes Index 2018: Enforcement, Thursday 12 April 2018

  • Insights| March 26, 2018

    Labor Court Case TT 2018:18 specifies employers’ equal treatment obligations after a transfer of business

  • Events| March 15, 2018

    Roschier and the International Trademark Association (INTA) are hosting INTA Roundtable: 3D Trademarks – What´s New? 20 March 2018

  • Insights| March 15, 2018

    Pharmaceutical Regulatory case – Roschier successfully represented Astellas Pharma in the Court of Justice of the European Union

  • Insights| March 6, 2018

    Telia margin squeeze saga takes new turn in Court of Appeal

  • Events| March 5, 2018

    Roschier Think Tech® – A holistic view on intangibles in an IoT world

  • Insights| March 1, 2018

    Judgment of the CJEU on off-label use of medicinal products in Hoffmann-La Roche et. al. v. AGCM

  • Insights| February 28, 2018

    Investing with China – Risk and Reward in China Related M&A, part II

  • Insights| February 28, 2018

    Finnish Competition and Consumer Authority takes on new public procurement enforcement powers with vigor – proposes fines of EUR 20 000 on City of Loviisa and City of Jämsä for illegal direct awards of contracts and issues two notices

  • Insights| February 23, 2018

    A new Finnish Arbitration Act?

  • Insights| February 19, 2018

    Investing with China – Risk and reward in China related M&A, part I

  • Insights| February 8, 2018

    Doing business in Finland 2018

  • Insights| February 6, 2018

    AG Wahl provides fresh opinion on gun-jumping in EY/KPMG DK

  • Insights| January 31, 2018

    Stockholm as a Global Hub for Arbitration

  • Insights| January 30, 2018

    Qualcomm receives EUR 997 million fine for abusing its dominant position

  • Insights| January 30, 2018

    Judgment after Swedish Competition Authority’s long-running investigation – Nasdaq did not abuse its dominant position

  • Insights| January 22, 2018

    Self-assessment of the legality of joint bids – a tricky task for the courts

  • Insights| January 22, 2018

    Government’s draft proposal for Interest Deduction Limitation Rules published for comments

  • Events| January 19, 2018

    Roschier is the main sponsor of the Helsinki Brand Summit

  • Insights| January 15, 2018

    One year of the amended Employment Contracts Act – Practical experiences from the reforms

  • Insights| January 2, 2018

    The Finnish Market Court imposes only moderate fines in the Bus Cartel case

  • Insights| January 2, 2018

    The Finnish Supreme Court has decided to seek a preliminary ruling from the CJEU in the Asphalt Cartel damages case

  • Insights| November 13, 2017

    Getting the Deal Through: Merger Control 2018 (Finland)

  • Events| March 2, 2017

    Roschier Topical Forum: Taking advantage of IPRs; taxation and strategies

  • Events| November 2, 2016

    Roschier Topical Forum focusing on compliance and criminal law related risks

  • Events| October 3, 2016

    Breakfast seminar on brands for DIF members 27 September 2016